Stillwell Richard Newcomb
SEC Form 4 insider trading activity
Stillwell Richard Newcomb has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 9, 2026.
On the most recent filing, Stillwell Richard Newcomb is listed as Director at Tonix Pharmaceuticals Holding Corp. Inside the rolling window, Stillwell Richard Newcomb reported 1 open-market purchase totaling $58K in TNXP and no open-market sales.
Companies traded
Other insiders at TNXP
Insider Buying
$58K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stillwell Richard Newcomb made?
Stillwell Richard Newcomb has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Stillwell Richard Newcomb trade?
Stillwell Richard Newcomb has filed SEC Form 4 disclosures for 1 company, including TNXP.
When was Stillwell Richard Newcomb's most recent SEC Form 4 filing?
Stillwell Richard Newcomb's most recent SEC Form 4 filing on Tracefour is dated Jun 9, 2026.
What is Stillwell Richard Newcomb's total buy and sell value in the current window?
Inside the rolling retention window, Stillwell Richard Newcomb bought $58K and sold $0 based on SEC Form 4 filings.
What was Stillwell Richard Newcomb's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,000 TNXP shares on 2026-06-08, worth $58K, per SEC Form 4 filings.